Ovarian vein embolization for pelvic venous congestion syndrome in women: A retrospective analysis of a clinical case series
DOI:
https://doi.org/10.37800/RM.3.2025.553Keywords:
ovarian vein embolization, chronic pelvic pain, visual analog scale, venous reflux, endovascular treatment, pelvic venous congestion syndrome (PVCS)Abstract
Relevance: Pelvic venous congestion syndrome (PVCS) is a chronic and often underdiagnosed vascular disorder in women of reproductive age, primarily manifested by persistent pelvic pain. Impaired venous outflow, characterized by reflux and dilatation of ovarian and pelvic veins, is considered the primary mechanism. Endovascular embolization has emerged as a safe, minimally invasive treatment that provides significant symptom relief.
The study aimed to evaluate the efficacy and safety of endovascular ovarian vein embolization in women diagnosed with pelvic venous congestion syndrome.
Materials and Methods: A retrospective analysis included 17 women (18–50 years) with clinically and radiologically confirmed PVCS who underwent ovarian vein embolization at the Syzganov National Scientific Center of Surgery (Almaty, Kazakhstan) in 2023–2024. Diagnosis was based on Doppler ultrasound, CT venography, and catheter-based phlebography. Embolization was performed using coils and sclerosing agents. Pain intensity was evaluated by the Visual Analog Pain Scale (VAPS) before and after surgery (Day 1, Day 3, 1 month, 3 months). Statistical analysis was performed using the Wilcoxon signed-rank test, with p < 0.05 considered significant.
The article also presents a clinical case of PVCS with pelvic varicose vein disease.
Results: Ovarian vein reflux (Hiromura grade II-III) was detected in 88.2% of patients, predominantly on the left side. VAPS scores decreased from a median of 6.0 (IQR 5-7) preoperatively to 2.0 (IQR 1-3) at 3 months (p < 0.001). No major peri- or post-procedural complications occurred. Three women (17.6%) required re-embolization due to contralateral reflux. Overall, 82.4% of patients reported partial or complete symptom resolution.
Conclusions: Endovascular ovarian vein embolization is a safe and effective treatment for PVCS, resulting in long-term reductions in pelvic pain and improvements in quality of life. Integration of multidisciplinary diagnostic criteria and SVP classification may further optimize patient selection and outcomes.
References
1. Dewald CL, Becker LS, Meyer BC. Interventional treatment of pelvic venous disorders. Fortschr Röntgenstr. 2024;196(5):921-927.
https://doi.org/10.1055/a-2229-4100
2. Basile A, Failla G, Gozzo C. Pelvic Congestion Syndrome. Semin Ultrasound CT MR. 2021;42(1):3-12.
https://doi.org/10.1053/j.sult.2020.07.001
3. Campbell B, Goodyear S, Franklin I, Nyamekye I, Poskitt K. Investigation and treatment of pelvic vein reflux associated with varicose veins: Current views and practice of 100 UK vascular specialists. Phlebology. 2020;35(1):56-61.
https://doi.org/10.1177/0268355519848621
4. Khilnani NM, Meissner MH, Learman LA, Gibson KD, Daniels JP, Winokur RS, Rosenblatt M. Research priorities in pelvic venous disorders in women: recommendations from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2019;30(6):781-789.
https://doi.org/10.1016/j.jvir.2018.10.008
5. Meissner MH, Khilnani NM, Labropoulos N, Gasparis AP, Gibson K, Greiner M, Rosenblatt M. The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: a report of the AVLS international working group. Phlebology. 2021;36(5):342-360.
https://doi.org/10.1016/j.jvsv.2020.12.084
6. Kashef E, Evans E, Patel N, Shaida N, Lopez A, Patel J, Majdalany B. Pelvic venous congestion syndrome: female venous congestive syndromes and endovascular treatment options. CVIR Endovasc. 2023;6:25.
https://doi.org/10.1186/s42155-023-00365-y
7. Hartung O. Embolization is essential in the treatment of leg varicosities due to pelvic venous insufficiency. Phlebology. 2015;30(1_suppl):81–85.
https://doi.org/10.1177/0268355515569129
8. De Gregorio MA, Guirola JA, Alvarez-Arranz E, Sanchez-Ballestin M, Urbano J, Sierre S. Pelvic venous disorders in women due to pelvic varices: treatment by embolization: experience in 520 patients. J Vasc Interv Radiol. 2020;31(10):1560-1569.
https://doi.org/10.1016/j.jvir.2020.06.017
9. Osman AM, Mordi A, Khattab R. Female pelvic congestion syndrome: how can CT and MRI help in the management decision? Br J Radiol. Jan 2021;94(1118):20200881.
https://doi.org/10.1259/bjr.20200881
10. Borghi C, Dell’Atti L. Pelvic congestion syndrome: the current state of the literature. Arch Gynecol Obstet. Feb 2016;293(2):291–301.
https://doi.org/10.1007/s00404-015-3895-7
11. Mahmoud O, Vikatmaa P, Aho P, Venermo M, Albäck A. Efficacy of endovascular treatment for pelvic congestion syndrome. J Vasc Surg Venous Lymphat Disord. Jul 2016;4(3):355–370.
https://doi.org/10.1016/j.jvsv.2016.01.002
12. Brown CL, Rizer M, Alexander R, Sharpe EE III, Rochon PJ. Pelvic congestion syndrome: systematic review of treatment success. Semin Intervent Radiol. Mar 2018;35(1):35–40.
https://doi.org/10.1055/s-0038-1636519
13. Corrêa MP, Bianchini L, Saleh JN, Noel RS, Bajerski JC. Pelvic congestion syndrome and embolization of pelvic varicose veins. J Vasc Bras. Nov 2019;18:e20190061.
https://doi.org/10.1590/1677-5449.190061
14. Илиев С.А., Турсынбаев С.Е., Джумабеков А.Т. Эндоваскулярные методы в лечении синдрома тазового венозного полнокровия. Ангиология и сосудистая хирургия. 2025;31(2 Suppl):171-173.
Iliev SA, Tursynbaev SE, Dzhumabekov AT. Endovascular methods in the treatment of pelvic venous congestion syndrome. Angiology and Vascular Surgery. 2025;31(2 Suppl):171-173. Russian.
https://www.angiolsurgery.org/events/2025/06/12-14/thesis.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 А. Кожамкул, А. Садуакас, Е. Абилханов, А. Сапунов, О. Бозбаев, А. Беркинбай

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
